• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

New European NABIHEAL project on biomaterials for the treatment of microbial infections
17 January 2023

New European NABIHEAL project on biomaterials for the treatment of microbial infections

Today we can already communicate that, this January, Nanomol Technologies starts an exciting European project, the Horizon Europe NABIHEAL project. This time, by the hand of the Center for Biomedical Research Network (CIBER) of the Institut de Ciencia de Materiales de Barcelona (ICMAB-CSIC) as coordinator.  In this project we participate in the biomaterials scale up tasks and co-lead the Business Development & Exploitation work package together with Histocell SL. 

NABIHEAL stands for "Antimicrobial Nanostructured Biomaterials for Complex Wound Healing" and aims to solve two unmet medical needs in complex wound healing 

  1. Affordable treatments for wound infections and prevention of complications during healing. 
  2. A strategy to optimize the composition and efficacy of wound dressings.  

The NABIHEAL project wants to advance the synthesis of advanced biomaterials as an alternative to commonly used silver-based materials. The most common antimicrobial products for treating microbial infections are silver-based. However, they have several economic, environmental and safety drawbacks.  

The project aims to obtain innovative multifunctional biomaterials for wound healing using affordable EU-based manufacturing technologies. In the long term, NABIHEAL could become a revolutionary alternative to silver in wound healing dressings.  

The project was launched on January 11-12, 2023 in Barcelona with the first meeting of the international consortium, formed by 14 partners from 7 countries, including research centers, universities and private companies.   

The kick-off meeting, held at the CSIC Residence for Researchers in Barcelona, was inaugurated by the project coordinator, Nora Ventosa, from CIBER and ICMAB-CSIC, and by institutional and political representatives, including Riccardo Rurali, Vice-Director of ICMAB-CSIC; Ramon Martínez Mañez, Scientific Director of CIBER-BBN; Jordi Aguasca, Director of the Transformation and Technological Disruption Unit of ACCIÓ; and Xavier Aldeguer, General Director of the Knowledge Society, Transfer and Territory of the Generalitat de Catalunya.  

In addition to the Center for Biomedical Research Network (CIBER) of the Institut de Ciencia de Materials de Barcelona (ICMAB-CSIC), which acts as project coordinator, the international consortium is made up of the following centers and companies:  

Spain: 

  • Center for Biomedical Research Network (CIBER) of the University of Extremadura and the University of Cantabria. 
  • Consejo Superior de Investigaciones Científicas (CSIC). 
  • Nanomol Technologies S.L. (NT). 
  • Bioiberica S.A.U (BIO). 
  • Histocell S.L. (HCELL). 
  • University of Granada (UGR). 
  • Asphalion (ASPH). 

Germany: 

  • MyBiotech GmbH (MyB). 
  • Charité-Universitätsmedizin Berlin (CH). 

Croatia: 

  • Institute for Medical Research and Occupational Health (IMI). 

Denmark: 

  • Aarhus University (AU). 

Israel: 

  • Technion-Israel Institute of Technology (IT). 

Austria: 

  • BioNanoNet Forschungsgesellschaft mbH (BNN). 

Slovenia: 

  • University of Maribor (UM). 

For more information, we attach the press release below: Download PDF

Related
news

World Health Day 07 April 2022

World Health Day

Nanomol Technologies has participated in a Nanotechnology Conference applied to Medicine for Health Professionals 08 June 2018

Nanomol Technologies has participated in a Nanotechnology Conference applied to Medicine for Health Professionals

Nanomol Technologies are going to participate in Farmaforum 2020 03 March 2020

Nanomol Technologies are going to participate in Farmaforum 2020

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2025

Nanomol Technologies S.L.

Site by Suki